Literature DB >> 7512973

BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain.

D M Jaworski1, G M Kelly, S Hockfield.   

Abstract

Hyaluronan (HA) is a ubiquitous component of the extracellular matrix of all tissues. In the mammalian central nervous system (CNS) HA is present throughout development and into adulthood. While the functions of HA are likely to be mediated by HA-binding proteins, no cell or tissue specific HA-binding proteins have been reported. In an effort to characterize the composition of the extracellular matrix of the CNS, we sought to identify neural HA-binding proteins. We report here the isolation and characterization of a cDNA with a high degree of sequence homology to members of the proteoglycan tandem repeat (PTR) family of HA-binding proteins. Unlike other HA-binding proteins, the expression of this cDNA is restricted to the CNS. We propose the name BEHAB, Brain Enriched HyAluronan Binding protein, for this gene. The expression of BEHAB mRNA is developmentally regulated; expression is first detected in the late embryonic period and peaks during the first two postnatal weeks. In the embryo, BEHAB is expressed at highest levels in mitotically active cells. The sequence of BEHAB has long stretches of identity between rat and cat, suggesting that the encoded protein is functionally important. The size and sequence of BEHAB are consistent with the possibility that it could serve a function like link protein, stabilizing interactions between HA and brain proteoglycans. These observations suggest that existence of other tissue specific HA-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512973      PMCID: PMC2120027          DOI: 10.1083/jcb.125.2.495

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  71 in total

1.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

2.  A brain extracellular matrix proteoglycan forms aggregates with hyaluronan.

Authors:  M Iwata; T N Wight; S S Carlson
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

3.  Histochemical demonstration of sulphated polysaccharides at the surface coat of nerve cells in the mouse central nervous system.

Authors:  H V Castejón
Journal:  Acta Histochem       Date:  1970       Impact factor: 2.479

4.  Glycosaminoglycans of brain during development.

Authors:  R U Margolis; R K Margolis; L B Chang; C Preti
Journal:  Biochemistry       Date:  1975-01-14       Impact factor: 3.162

5.  Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain.

Authors:  U Rauch; L Karthikeyan; P Maurel; R U Margolis; R K Margolis
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

6.  Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain.

Authors:  A Bignami; G Perides; F Rahemtulla
Journal:  J Neurosci Res       Date:  1993-01       Impact factor: 4.164

7.  A large chondroitin sulfate proteoglycan has the characteristics of a general extracellular matrix component of adult brain.

Authors:  M Iwata; S S Carlson
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

Review 8.  Nervous tissue proteoglycans.

Authors:  R K Margolis; R U Margolis
Journal:  Experientia       Date:  1993-05-15

9.  Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin.

Authors:  A L Prieto; C Andersson-Fisone; K L Crossin
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Identification of hyaluronic acid binding sites in the extracellular domain of CD44.

Authors:  R J Peach; D Hollenbaugh; I Stamenkovic; A Aruffo
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  29 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons.

Authors:  H Yamada; B Fredette; K Shitara; K Hagihara; R Miura; B Ranscht; W B Stallcup; Y Yamaguchi
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 4.  Does DG42 synthesize hyaluronan or chitin?: A controversy about oligosaccharides in vertebrate development.

Authors:  A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan.

Authors:  C Lander; H Zhang; S Hockfield
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

Review 6.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

7.  Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits.

Authors:  Diane M Jaworski; Paul Soloway; John Caterina; William A Falls
Journal:  J Neurobiol       Date:  2006-01

8.  Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan.

Authors:  M F Meyer; G Kreil
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  The divergent homeobox gene PBX1 is expressed in the postnatal subventricular zone and interneurons of the olfactory bulb.

Authors:  L Redmond; S Hockfield; M A Morabito
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

10.  Brevican knockdown reduces late-stage glioma tumor aggressiveness.

Authors:  Chrissa A Dwyer; Wenya Linda Bi; Mariano S Viapiano; Russell T Matthews
Journal:  J Neurooncol       Date:  2014-07-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.